Opsalin: A phase II placebo (Pbo)-controlled randomized study of ombrabulin in patients with platinum-sensitive recurrent ovarian cancer (OC) treated with carboplatin (Cb) and paclitaxel (P)

被引：0
|
作者：
Birrer, Michael J.
Bondarenko, Igor
Tjulandin, Sergei
Vergote, Ignace
Cibula, David
Ray-Coquard, Isabelle
Colombo, Nicoletta
Allard, Aurore
Oprea, Corina
Rey, Augustin A.
Sessa, Cristiana
Pujade-Lauraine, Eric
机构：
[1] Massachusetts Gen Hosp, Dana Farber Harvard Canc Ctr, Boston, MA 02114 USA
[2] Dnipropetrovsk Med Acad, Dnepropetrovsk, Ukraine
[3] NN Blokhin Russian Canc Res Ctr, Moscow, Russia
[4] Katholieke Univ Leuven Hosp, Louvain, Belgium
[5] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[6] Ctr Leon Berard, F-69373 Lyon, France
[7] Ist Europeo Oncol, Milan, Italy
[8] Sanofi, Chilly Mazarin, France
[9] Sanofi, Vitry Sur Seine, France
[10] Ist Oncol Svizzera Italiana, Bellinzona, Switzerland
[11] Hop Hotel Dieu, F-75181 Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5516
引用
收藏
页数：1
相关论文
共 50 条
  • [1] OPSALIN: A phase II placebo-controlled randomized study of ombrabulin in patients with platinum-sensitive recurrent ovarian cancer treated with carboplatin (Cb) and paclitaxel (P).
    Pujade-Lauraine, Eric
    Vergote, Ignace B.
    Allard, Aurore
    Rey, Augustin A.
    Sessa, Cristiana
    Birrer, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Nedaplatin and paclitaxel comparedwith carboplatin and paclitaxel for patients with platinum-sensitive recurrent ovarian cancer
    Ge, L.
    Li, N.
    Wu, L. Y.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 33 - 34
  • [3] Nedaplatin and paclitaxel compared with carboplatin and paclitaxel for patients with platinum-sensitive recurrent ovarian cancer
    Ge, Li
    Li, Ning
    Yuan, Guang-Wen
    Sun, Yang-Chun
    Wu, Ling-Ying
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (06): : 1074 - 1082
  • [4] Phase II Study of Carboplatin and Pemetrexed for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
    Matulonis, Ursula A.
    Horowitz, Neil S.
    Campos, Susana M.
    Lee, Hang
    Lee, Julie
    Krasner, Carolyn N.
    Berlin, Suzanne
    Roche, Maria R.
    Duska, Linda R.
    Pereira, Lauren
    Kendall, Deborah
    Penson, Richard T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) : 5761 - 5766
  • [5] Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer
    Matulonis, U.
    Richard, P.
    Campos, S.
    Bryan, J.
    Lee, J.
    Kendal, D.
    Krasner, C.
    Berlin, S.
    Roche, M.
    Duska, L.
    Pereira, L.
    Horowitz, N.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S23 - S24
  • [6] Phase I pharmacology study of carboplatin and weekly paclitaxel in platinum-sensitive ovarian cancer patients with recurrent disease
    Aghajanian, C
    Sabbatini, P
    Hensley, M
    Spriggs, D
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 42 - 42
  • [7] Randomized phase III study comparing paclical-carboplatin with paclitaxel-carboplatin in patients with recurrent platinum-sensitive epithelial ovarian cancer.
    Vergote, Ignace
    Brize, Arija
    Lisyanskaya, Alla Sergeevua
    Lichinitser, Mikhail
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients
    Viens, P
    Petit, T
    Yovine, A
    Bougnoux, P
    Deplanque, G
    Cottu, PH
    Delva, R
    Lotz, JP
    Belle, SV
    Extra, JM
    Cvitkovic, E
    ANNALS OF ONCOLOGY, 2006, 17 (03) : 429 - 436
  • [9] A phase II nonrandomized study of nab-paclitaxel plus carboplatin in patients with recurrent platinum-sensitive ovarian or primary peritoneal cancer
    Benigno, B. B.
    Burrell, M. O.
    Daugherty, P.
    Hernandez, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer
    Eisenhauer, Eric L.
    Zanagnolo, Vanna
    Cohn, David E.
    Salani, Ritu
    O'Malley, David M.
    Sutton, Gregory
    Callahan, Michael J.
    Cobb, Bobbi
    Fowler, Jeffrey M.
    Copeland, Larry J.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 262 - 266
12345